Before taking its repurposed diabetes drug candidate into a phase 2 lupus trial, Conduit Pharmaceuticals is tapping Charles ...
The funding agreement comes as Biogen revealed a modest Q4 sales beat, which analysts expect will be “overshadowed” by the ...
Verywell Health on MSN10d
How to Recognize and Treat a Sun Rash
Medically reviewed by Brendan Camp, MD Polymorphic light eruption (PMLE), commonly known as a sun rash or sun poisoning, is a type of photodermatosis triggered by an immune system reaction to the ...
Personalized medicine advances as autologous cell therapy grows, leveraging refined cell collection, improved processing ...
Objective Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role in cutaneous autoimmune diseases, such as cutaneous lupus erythematosus (CLE ...
From being in depression and being diagnosed with bipolar disorder to her kidney transplant and being diagnosed with lupus, she has been ... kind and set alcohol and drug narratives at the time ...
found that 27% of individuals with systemic lupus erythematosus (SLE) had hearing loss. This was significantly higher than in the control group. Participants with SLE showed worse hearing at lower ...
Current treatment options for systemic lupus erythematosus (SLE ... is being treated for a disease flare or shortly thereafter. Drugs most commonly used in this setting are antimalarials and ...
Hypoglycemia (low blood sugar) is not a formal symptom of lupus, but it may develop from related factors like medication use, other autoimmune processes in the body, and hormonal changes.
BACKGROUND: Statins have been increasingly associated with drug-induced autoimmune reactions, including lupus erythematosus. OBJECTIVE: To identify and determine the clinical and biological ...
An investigator-initiated Phase 1/2 trial of CNTY-101, an investigational therapy, has been announced for the treatment of B-cell mediated autoimmune diseases, including systemic lupus erythematosus .
Long-term use of glucocorticoids (GCs) for the treatment of lupus is very common, however, it has also been associated with side effects like high blood pressure, diabetes, infection, and osteoporosis ...